March 08, 2016
Article
Evidence-Based Oncology
Results of the study in JAMA underscore the importance of advance care planning.
March 07, 2016
Article
Evidence-Based Oncology
Panelists discussing quality metrics in oncology were not sure payment and federal policies could keep pace with what's happening on the front lines.
March 07, 2016
Article
Evidence-Based Oncology
CMS has attempted to tailor ACOs to meet a variety of needs and levels of risk, depending on where parties are in their knowledge level of payment reform.
March 07, 2016
Article
Evidence-Based Oncology
Yousuf Zafar, MD, MHS, found that most cancer patients would like to discuss financial concerns with their doctors, but few actually do, for a variety of reasons.
March 06, 2016
Article
Evidence-Based Oncology
Flatiron Health seeks to use data to prevent the patient experience from being lost.
March 05, 2016
Article
Evidence-Based Oncology
The pharmacy benefit manager may be the "new sheriff in town" in an era of rising costs.
March 04, 2016
Article
Evidence-Based Oncology
Choosing a therapy with fewer side effects can increase efficacy because patients stick with it, said Stacey McCullough, PharmD, of Tennessee Oncology.
March 04, 2016
Article
Evidence-Based Oncology
Immunotherapy represents the "next frontier" in cancer care, according to Joseph Alvarnas, MD, of City of Hope, who is editor-in-chief of Evidence-Based Oncology.
March 04, 2016
Article
Evidence-Based Oncology
After being diagnosed with a rare blood cancer, Jack Whelan has used his electronic connections to be more involved in his care.
March 03, 2016
Article
Evidence-Based Oncology
Broad treatment guidelines may be based on relatively narrow trial data.
March 03, 2016
Article
Evidence-Based Oncology
Oncologists now face a cost discussion that was not part of their medical training. It's a balancing act between the big picture of understanding the burdens on the system and "the patient in front of you."
March 03, 2016
Article
Evidence-Based Oncology
Keynote speaker Dr Julie Vose said the oncologist faces many administrative burdens in the transition to value-based care. Solving them is essential to spending more time with the patient.
March 02, 2016
Article
Evidence-Based Oncology
The timely panel took place just after FDA issued a report on why it feels regulatory oversight of testing is necessary.
March 02, 2016
Article
Evidence-Based Oncology
A thorough family history is the foundation of precision medicine, according to the 2015 president of the National Society of Genetic Counselors.
March 02, 2016
Article
Evidence-Based Oncology
Emanuel F. Petricoin III, PhD, said patients have much to gain from "democratization" as clinical trials move beyond academic centers.